US Compounding Inc. is recalling approximately 2,058 units of Buprenorphine HCl in various forms, including oral suspensions and transdermal gels. This recall was initiated because the Active Pharmaceutical Ingredient (API) was used after its manufacturer-assigned expiration date. Using expired ingredients can result in medication that is less potent or stable than required, potentially leading to ineffective treatment for the animals receiving it. These products were distributed to veterinary clinics and pharmacies in AR, FL, MN, OR, PA, and VA.
The use of an expired active ingredient may lead to decreased drug effectiveness or unforeseen chemical degradation. For animals being treated with Buprenorphine for pain management, this could result in inadequate pain relief or unexpected side effects.
Refund or replacement for expired compounded medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response